Trends in catheter ablation for atrial fibrillation in the United States

Journal of Hospital Medicine

Volumn 4, Issue 7, 2009, Pages

  Kneeland, Patrick P ^a   Fang, Margaret C ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Atrial fibrillation; Catheter ablation; Elderly; National trends

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CATHETER ABLATION; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEALTH INSURANCE; HEART ATRIUM FIBRILLATION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SEX RATIO; STROKE; TRANSIENT ISCHEMIC ATTACK; UNITED STATES;

AGED; ATRIAL FIBRILLATION; CATHETER ABLATION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; RISK FACTORS; UNITED STATES;

EID: 70450003685     PISSN: 15535592     EISSN: 15535606     Source Type: Journal    
DOI: 10.1002/jhm.445     Document Type: Article

References (30)

1. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285(18):2370-2375.
2. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med. 1994;154(13): 1449-1457.
3. Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med. 2002;113(5):359-364. (Pubitemid 35223606)
4. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med. 1995;98(5):476-484.
5. Poole-Wilson PA, Swedberg K, Cleland JG, et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomized controlled trial. Lancet. 2003;362(9377):7-13. (Pubitemid 36835815)
6. Maggioni AP, Latini R, Carson PE, et al. Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT). Am Heart J. 2005;149(3):548-557. (Pubitemid 40585420)
7. Wolf PA, Mitchell JB, Baker CS, Kannel WB, D'Agostino RB. Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med. 1998;158(3):229-234. (Pubitemid 28123885)
8. Le Heuzey JY, Paziaud O, Piot O, et al. Cost of care distribution in atrial fibrillation patients: the COCAF study. Am Heart J. 2004;147(1):121-126. (Pubitemid 38037407)
9. Crijns HJ, Van Gelder IC, Van Gilst WH, Hillege H, Gosselink AM, Lie KI. Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter. Am J Cardiol. 1991;68(4):335-341.
10. Roy D, Talajic M, Dorian P, et al. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med. 2000;342(13):913-920.
11. Van Gelder IC, Crijns HJ, Tieleman RG, et al. Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation. Arch Intern Med. 1996; 156(22):2585-2592.
12. Oral H, Pappone C, Chugh A, et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med. 2006;354(9):934-941. (Pubitemid 43313660)
13. Chugh A, Morady F. Atrial fibrillation: catheter ablation. J Interv Card Electrophysiol. 2006;16(1):15-26.
14. Packer DL, Asirvatham S, Munger TM. Progress in nonpharmacologic therapy of atrial fibrillation. J Cardiovasc Electrophysiol. 2003;14(12 Suppl):S296-S309. (Pubitemid 38037459)
15. Mickelsen S, Dudley B, Treat E, Barela J, Omdahl J, Kusumoto F. Survey of physician experience, trends and outcomes with atrial fibrillation ablation. J Interv Card Electrophysiol. 2005;12(3):213-220. (Pubitemid 41201695)
16. Gerstenfeld EP, Callans D, Dixit S, et al. Characteristics of patients undergoing atrial fibrillation ablation: trends over a seven-year period 1999-2005. J Cardiovasc Electrophysiol. 2007;18(1):23-28.
17. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006;114(7):e257-e354. (Pubitemid 44252297)
18. Lakkireddy D, Patel D, Ryschon K, et al. Safety and efficacy of radiofrequency energy catheter ablation of atrial fibrillation in patients with pacemakers and implantable cardiac defibrillators. Heart Rhythm. 2005; 2(12):1309-1316. (Pubitemid 43055412)
19. Cappato R, Calkins H, Chen SA, et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation. 2005;111(9):1100-1105. (Pubitemid 40365469)
20. Khaykin Y, Morillo CA, Skanes AC, McCracken A, Humphries K, Kerr CR. Cost comparison of catheter ablation and medical therapy in atrial fibrillation. J Cardiovasc Electrophysiol. 2007;18(9):907-913. (Pubitemid 47342400)
21. Wazni OM, Marrouche NF, Martin DO, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA. 2005;293(21):2634-2640. (Pubitemid 40744248)
22. Pappone C, Augello G, Sala S, et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. J Am Coll Cardiol. 2006;48(11): 2340-2347. (Pubitemid 44856763)
23. Fang MC, Chen J, Rich MW. Atrial fibrillation in the elderly. Am J Med. 2007;120(6):481-487.
24. O'Neill MD, Jaïs P, Hocini M, Sacher F, Klein GJ, Clémenty J, Haïssaguerre M. Catheter ablation for atrial fibrillation. Circulation. 2007;116(13): 1515-1523.
25. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol. 1994;74(3):236-241. (Pubitemid 24239044)
26. Calkins H, Brugada J, Packer DL, et al. HRS/EHRA/ECAS Expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. European Heart Rhythm Association (EHRA), European Cardiac Arrhythmia Scoiety (ECAS), American College of Cardiology (ACC), American Heart Association (AHA), Society of Thoracic Surgeons (STS). Heart Rhythm. 2007;4(6):816-861.
27. U.S. Department of Health and Human Services, Public Health Service, National Center for Health Statistics National Hospital Discharge Survey 1990-2005. Multi-Year Public-Use Data File Documentation. Available at: http://www.cdc.gov/nchs/about/major/hdasd/nhds.htm. Accessed December 2008.
28. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001;285(22): 2864-2870. (Pubitemid 32537350)
29. Wood MA, Brown-Mhoney C, Kay GN, Ellenbogen KA. Clinical outcomes after ablation and pacing therapy for atrial fibrillation: a meta-analysis. Circulation. 2000; 101(10):1138-1144. (Pubitemid 30146615)
30. Hsu LF, Jaïs P, Sanders P, et al. Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med. 2004; 351(23):2373-2383. (Pubitemid 40500183)